Brief, Culturally Sensitive Screener Helps Primary Care Providers Diagnose Dementia
July 18, 2024
A brief and culturally fair cognitive assessment tool, paired with ...
Read More
Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders
July 15, 2024
Placebo is the most studied therapeutic agent in neuroscience as th...
Read More
Association Between Dual Orexin Receptor Antagonists And Suicidality
July 7, 2024
A recent study explored whether dual orexin receptor antagonists (D...
Read More
FDA Approves New Alzheimer's Treatment
July 2, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Valproate Use During Spermatogenesis and Risk to Offspring
June 28, 2024
While the teratogenic risks associated with maternal exposure to th...
Read More
FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy
June 25, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
June 21, 2024
Bipolar disorder (BD) often appears after onset of major depressive...
Read More
Long-Term Study Confirms Safety and Efficacy of High-Dose SSRIs in OCD
June 9, 2024
The current FDA-recommended doses of serotonin reuptake inhibitors ...
Read More
Digital Tool for Binge-Eating Disorder
June 7, 2024
Although cognitive behavioral therapy has demonstrated efficacy as ...
Read More
Addressing Mental Healthcare in the LGBTQ+ Community
June 1, 2024
June is Pride Month and it’s important to understand the barriers t...
Read More
FDA Approves Liquid Non-Stimulant ADHD Medication
May 31, 2024
The US FDA has approved once-daily clonidine hydrochloride extended...
Read More
Interactions of CBD and THC with CYP450 Enzymes
May 30, 2024
A recent systematic review evaluated the effect of CBD and THC on t...
Read More